CareView Communications Announces Expansion Of Patent Portfolio
CareView Communications, Inc. an information technology provider to the healthcare industry, today announced that for the six-months ended June 30, 2021, the U.S. Patent and Trademark Office issued or allowed eight additional patents related to the Company’s CareView System.
Recommended AI News: Shipsy sets sight at global expansion by deepening its Middle Eastern Presence, targets 3X client amplification
“These new patents greatly strengthen our diverse and growing portfolio related to patient safety products. We strive to continually update and upgrade our technology to best serve the patients and healthcare systems using our product line,” said Steven Johnson, the Company’s President and CEO.
Some of these concepts include:
- Method for monitoring and controlling bed functions through smart bed integration.
- Method to expand existing patent for patient monitoring systems to include 3D sensors more indicative for a patient at high risk for falling.
- Method to expand existing patent for Virtual Rails® to include a plurality of zones which can be monitored for possible patient fall alerts.
- Method to expand existing patent for thermal sensors to determine location of and type of liquid to generate an alert that a patient is bleeding out or has pulled out their catheter, among other things.
- Method to expand existing patent for electronic SitterView® platform.
“These patents represent CareView’s dedication to research and development, continuing our commitment to reinventing the standard of care. These patents expand on our SitterView and Virtual Rails technology, allowing remote sitters to safely monitor up to 40 patients at the same time. In addition, these patents cover the usage of new sensors, such as depth (3D) and thermal sensors, to solve some of the latest problems seen in hospitals,” said Sandra McRee, CareView’s Chief Operating Officer.
Recommended AI News: Panion Announces Major Rebrand, Pivot to B2B SaaS Community Management Platform
Comments are closed.